EPISODE · Oct 6, 2025 · 1H 9M
Inside the Glycocalyx: The Science Behind Your Body’s Inner Shield
from You’re the Cure w/ Dr. Ben Edwards · host Veritas Medical
In this powerful episode, Dr. Ben Edwards sits down with vascular researcher Dr. Hans Vink and Bob Long, CEO and co-founder of the Glycocalyx Research Institute, to uncover the groundbreaking science behind the glycocalyx — your body’s invisible shield for vascular health. You’ll hear Bob’s remarkable personal story of reversing his own heart symptoms and type 2 diabetes through glycocalyx restoration, and Dr. Vink’s fascinating journey to discover and photograph this vital “slippery” layer that lines 60,000 miles of capillaries. Together, they explain how damage to the glycocalyx — from stress, toxins, and spike protein — drives inflammation, blood clots, and organ decline, and how new diagnostic tools and natural therapies are helping to restore it. Glycocalyx Support Supplement "ReVasca": Purchase Here Member Discount: Purchase Here
What this episode covers
In this powerful episode, Dr. Ben Edwards sits down with vascular researcher Dr. Hans Vink and Bob Long, CEO and co-founder of the Glycocalyx Research Institute, to uncover the groundbreaking science behind the glycocalyx — your body’s invisible shield for vascular health. You’ll hear Bob’s remarkable personal story of reversing his own heart symptoms and type 2 diabetes through glycocalyx restoration, and Dr. Vink’s fascinating journey to discover and photograph this vital “slippery” layer that lines 60,000 miles of capillaries. Together, they explain how damage to the glycocalyx — from stress, toxins, and spike protein — drives inflammation, blood clots, and organ decline, and how new diagnostic tools and natural therapies are helping to restore it. Glycocalyx Support Supplement "ReVasca": Purchase Here Member Discount: Purchase Here
NOW PLAYING
Inside the Glycocalyx: The Science Behind Your Body’s Inner Shield
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m